Drug
Asp3652
Asp3652: highest development phase Phase 1, developed by Astellas. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ASP3652 NCT02034734 | Phase 1 | Pharmacokinetics of ASP3652 |
| ASP3652 NCT02243657 | Phase 1 | Healthy Subjects |
Latest
No recent events.
Follow Asp3652 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.